PRESS RELEASE published on 11/14/2025 at 23:05, 5 months 26 days ago Inside Information / Operations of the issuer (acquisitions, sales...) MaaT Pharma successfully completes Global Offering of €9.1 million, strengthening financial position and supporting development of Microbiome Therapies for cancer patients Financial Position Global Offering MaaT Pharma Cancer Patients Microbiome Therapies
PRESS RELEASE published on 11/14/2025 at 23:05, 5 months 26 days ago Informations privilégiées / Opérations de l'émetteur (acquisitions, cessions...) MaaT Pharma annonce le succès de son Offre Globale de 9,1 millions d'euros pour le développement de Microbiome Ecosystem Therapies™. Levée de fonds pour Xervyteg® et MaaT033 Microbiome Ecosystem Therapies Offre Globale MaaT Pharma MaaT033 Xervyteg
BRIEF published on 11/13/2025 at 19:45, 5 months 27 days ago MaaT Pharma launches a capital increase Capital Increase Qualified Investors MaaT Pharma Global Offer Xervyteg® Marketing
BRIEF published on 11/13/2025 at 19:45, 5 months 27 days ago Lancement d'une augmentation de capital par MaaT Pharma Augmentation De Capital Investisseurs Qualifiés Offre Globale MaaT Pharma Xervyteg® Commercialisation
PRESS RELEASE published on 11/13/2025 at 19:40, 5 months 27 days ago Inside Information / Other news releases MaaT Pharma launches a capital increase of approximately €9 million through a private placement and PrimaryBid offering. Funds raised to support Xervyteg® commercialization and extend cash runway until summer 2026 Private Placement Investment Capital Increase MaaT Pharma Xervyteg
PRESS RELEASE published on 11/13/2025 at 19:40, 5 months 27 days ago Informations privilégiées / Autres communiqués MaaT Pharma lance une augmentation de capital de 9 millions d'euros pour financer son développement. Offre d'actions nouvelles aux investisseurs. Projets de développement clinique et commercialisation Développement Augmentation De Capital Commercialisation Actions Nouvelles MaaT Pharma
BRIEF published on 11/05/2025 at 07:35, 6 months 6 days ago MaaT Pharma Reveals Promising Preclinical Data for MaaT034 Cancer Treatment Immunotherapy MaaT Pharma Microbiome Therapy MaaT034
BRIEF published on 11/05/2025 at 07:35, 6 months 6 days ago MaaT Pharma dévoile des données précliniques prometteuses pour MaaT034 Immunothérapie Traitement Du Cancer MaaT Pharma Thérapie Du Microbiome MaaT034
PRESS RELEASE published on 11/05/2025 at 07:30, 6 months 6 days ago Inside Information / Other news releases MaaT Pharma presents updated preclinical data for MaaT034, showing immune activation and anti-tumor activity at SITC Annual Meeting. New findings enhance patient responses to immunotherapy Preclinical Data MaaT Pharma SITC Annual Meeting Immune Activation Anti-tumor Activity
PRESS RELEASE published on 11/05/2025 at 07:30, 6 months 6 days ago Informations privilégiées / Autres communiqués MaaT Pharma annonce des données précliniques actualisées pour MaaT034 au Congrès SITC, démontrant activation immunitaire et activité anti-tumorale MaaT Pharma Données Précliniques MaaT034 Activation Immunitaire Congrès SITC
Published on 05/11/2026 at 12:18, 23 minutes ago Caledonia Mining Corporation Plc - Abridged and Unaudited Quarterly Results and Details of Management Conference Call for the First Quarter Ended March 31, 2026 ("the Quarter" or "Q1 2026")
Published on 05/11/2026 at 09:05, 3 hours 36 minutes ago Ameriwest Outlines Multiple Additional Breccia Pipe-Style Targets at Bornite from Historical Soil Sampling and Mapping
Published on 05/11/2026 at 08:05, 4 hours 36 minutes ago Tocvan Accelerates Gran Pilar: 5,000+ Meters Drilled to Date, Historic Workings Discovered on South Block, Pilot Progresses
Published on 05/11/2026 at 12:15, 26 minutes ago ams OSRAM sells CMOS Image Sensor business to indie Semiconductor Inc. for EUR 40 million in cash, further concentrating its growth investments into AI Photonics and AR smart glasses
Published on 05/11/2026 at 11:36, 1 hour 5 minutes ago LION Smart and LEAPENERGY secure the performance of their storage containers through multiple guarantees
Published on 05/11/2026 at 11:17, 1 hour 24 minutes ago Aroundtown SA: Release of a capital market information
Published on 05/11/2026 at 11:10, 1 hour 31 minutes ago Original-Research: Schloss Wachenheim AG (von First Berlin Equity Research GmbH): Buy
Published on 05/11/2026 at 10:48, 1 hour 53 minutes ago GUILLEMOT CORPORATION | Weekly report share buyback from May 4 to May 8 2026
Published on 05/11/2026 at 10:48, 1 hour 53 minutes ago GUILLEMOT CORPORATION | Déclaration hebdomadaire des transactions sur actions propres du 4 au 8 mai 2026
Published on 05/11/2026 at 09:16, 3 hours 25 minutes ago ENGIE - Déclaration du nombre total d'actions et de droits de vote au 28 avril 2026
Published on 05/07/2026 at 19:15, 3 days 17 hours ago 2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 3 days 17 hours ago Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
